Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2018 Aug 8;89(4):399–407. doi: 10.1111/cen.13813

Figure 2:

Figure 2:

Comparison of 24-hour serial hormone levels on conventional glucocorticoid therapy (baseline) vs. continuous subcutaneous hydrocortisone infusion (CSHI) therapy for 6 and 18 months.